+86-571-8627 3270
Hubei Biocause Heilen Phamaceutical Co., Ltd.
29 YRS
Hubei, China
CNY 180 Million
139860 m²
500-1000 people
Main Products: Torasemide / Ibuprofen / Dexibuprofen / Ibuprofen Lysinate / Granisetron Hydrochloride / Tropisetron Hydrochloride / Dolasetron Mesylate / Fludarabine Phosphate / Abiraterone / Azacytidine / Clofarabine / Atropine Sulfate / Hyoscyamine Sulfate / Milrinone / Flumazenil / Cladribine / Homatropine Methyl Bromide / Oxaprozin / Balsalazide Sodium
Hubei, China
ABOUT US
Hubei Biocause Group is a public listed company, involves Pharmaceutical, Chemical and new energy fuel. The company is also the biggest share holder of two insurance companies (Life Insurance and Motor Insurance).Biocause’s pharmaceutical part involves Contract Research, Contract Manufacture and production of API, intermediates and formulations, including tablets, granules, capsules and etc.Biocause is one leading pharmaceutical producer and exporter in China, with strong Production, R&D and Quality system. The company has 8 APIs registered in FDA and 4 APIs with CEP. The company has passed US FDA inspections, EU GMP inspection all on first attempts, covering 3 API facilities and multi-APIs, including kilo production site as well as hundreds tons commercial site. The product has been exported to over 85 countries globally and half of them sold into regulatory market as USA and EU.
Basic Information
Tax ID
91420800615406429F
Country/Region
Hubei, China
Year Established
1995
Registered Capital
CNY 180 Million
Business Type
CRO
Total Employees
500-1000 people
Quality Management Certificate
other, SFDA-GMP, US-FDA
Total Annual Revenue
CNY 593 Million
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
It is mainly engaged in the R &D, production and sales of pharmaceutical raw materials and preparation products.
PLANT LOCATION
COMPANY ALBUM
厂房大门
厂房大门
厂房大门
其他图片
其他图片
其他图片
其他图片
其他图片
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >